Your browser doesn't support javascript.
loading
Intravitreal Nesvacumab (Anti-Angiopoietin-2) Plus Aflibercept in Neovascular AMD: Phase 2 ONYX Randomized Trial.
Heier, Jeffrey S; Ho, Allen C; Boyer, David S; Csaky, Karl; Vitti, Robert; Perlee, Lorah; Chu, Karen W; Asmus, Friedrich; Leal, Sergio; Zeitz, Oliver; Cheng, Yenchieh; Schmelter, Thomas; Brown, David M.
Affiliation
  • Heier JS; Ophthalmic Consultants of Boston, Boston, MA, USA.
  • Ho AC; Wills Eye Hospital, Philadelphia, PA, USA.
  • Boyer DS; Retina-Vitreous Associates Medical Group, Beverly Hills, CA, USA.
  • Csaky K; Retina Foundation of the Southwest, Dallas, TX, USA.
  • Vitti R; Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USA.
  • Perlee L; Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USA.
  • Chu KW; Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USA.
  • Asmus F; Bayer AG, Berlin, Germany.
  • Leal S; Bayer Consumer Care AG, Basel, Switzerland.
  • Zeitz O; Bayer AG, Berlin, Germany.
  • Cheng Y; Department of Ophthalmology, Charité Universitätsmedizin Berlin, Berlin, Germany.
  • Schmelter T; Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USA.
  • Brown DM; Bayer AG, Berlin, Germany.
J Vitreoretin Dis ; 7(1): 8-15, 2023.
Article in En | MEDLINE | ID: mdl-37008402
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: J Vitreoretin Dis Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: J Vitreoretin Dis Year: 2023 Document type: Article Affiliation country: Country of publication: